Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5029 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 29 out of 503
5029 citations found

Clinical Relevance of Plasma Prolylcarboxypeptidase Level in Patients with Idiopathic Acute Optic Neuritis

Kim, JH;Shin, DB;Suk, K;Chun, BY;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • n a 100 µL solution containing 50% complete Freund’s adjuvant and 10 mg/mL of a heat-killed H37Ra strain of Mycobacterium tuberculosis (Difco Laboratories, Detroit, MI, USA) [20]. Pertussis toxin (List Biological Laboratories, Campbell, CA, USA) dissolved in PBS (200 ng/mouse) was injected intraperitoneally on the day of immunization and again at 48 h post-immunization [20]. The mice were exami ... n a 100 µL solution containing 50% complete Freund’s adjuvant and 10 mg/mL of a heat-killed H37Ra strain of Mycobacterium tuberculosis (Difco Laboratories, Detroit, MI, USA) [20]. Pertussis toxin (List Biological Laboratories, Campbell, CA, USA) dissolved in PBS (200 ng/mouse) was injected intraperitoneally on the day of immunization and again at 48 h post-immunization [20]. The mice were exami

Chilean brush-tailed mouse (Octodon degus): a diurnal precocial rodent as a new model to study visual receptive field properties of superior colliculus neurons

Márquez, N;Fernández-Aburto, P;Deichler, A;Perales, I;Letelier, J;Marín, G;Mpodozis, J;Pallas, S;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • ojections to the SC was performed under gaseous anesthesia using isoflurane (4% in medical oxygen at a flow rate of 100 cc/kg/min) complemented with diazepam (5 mg/kg) administrated IP. A glass pipette (tip diameter 15-20 ?m) containing 1% cholera toxin subunit B (CTB, List Biological Laboratories, Campbell, CA) in 0.1 M phosphate buffer was injected intraocularly. After 5-7 days survival, the degus were sedated with gaseous isoflurane, placed in a deep state of anesthesia with ketamine/xylazine (ketamine 40-80 mg/kg, xylazine 5-10 mg/kg), and perfused intracardially by passing 200 ml of warm saline solution (0.9% in 0

CD4+Trm sustain the chronic phase of auto-immune neuroinflammatory disease

Pignata, A;Frieser, D;Hsiao, C;Engelenburg, H;Alis, M;Gonzalez-Fierro, C;Cazaentre, V;Miranda-Capet, R;Dufourd, E;Vermeulen, T;Aida, A;Gisbergen, K;Blanchard, N;Hamann, J;Smolders, J;Liblau, R;Masson, F;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • cton-Dikinson) in incomplete Freund’s adjuvant (Sigma-Aldrich-F5506). Pertussis toxin 200ng/ml (List Labs) was injected intravenously (i.v.) at days 0 and 2 post-immunization. The incidence and the severity of the disease were monitored daily and were evaluated as previously described (56). Isolation of CNS-infiltrating cells and assessment of cytokine production Mice were first anesthetized with an intraperitoneal (i.p.) injection of a solution of

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • onal communication). A mixture of rabies virus (CVS strain, 5.96?×?1010 PFU/ml) and the conventional tracer Cholera toxin B fragment (CTB low salt, end concentration 0.03%) (List Biological Labs, Campbell, CA) was injected in a single dose (2 ?l delivered over 30?min) into MSTl (2 monkeys), rostral MIP (2 monkeys) or LIPv (1 monkey) at midpoint of the rostrocaudal length of the IPS (Figure 1) using a Hamilton syringe driven by a micromanipulator. The injection needle was left in place for more than 30?min after the end of the injection. After recovery from general a

Rapamycin alleviates mitochondrial dysfunction in anti-NMDAR encephalitis mice

Kong, L;Yang, X;Sun, A;Yang, X;Zhao, X;Wang, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A multi-omics systems vaccinology resource to develop and test computational models of immunity

Shinde, P;Soldevila, F;Reyna, J;Aoki, M;Rasmussen, M;Willemsen, L;Kojima, M;Ha, B;Greenbaum, JA;Overton, JA;Guzman-Orozco, H;Nili, S;Orfield, S;Gygi, JP;da Silva Antunes, R;Sette, A;Grant, B;Olsen, LR;Konstorum, A;Guan, L;Ay, F;Kleinstein, SH;Peters, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A Mucosal Vaccine Formulation Against Tuberculosis by Exploiting the Adjuvant Activity of S100a4A Damage-Associated Molecular Pattern Molecule

Abil, O;Liu, S;Yeh, Y;WU, Y;Sen Chaudhuri, A;Shan Li, N;Deng, C;Xiang, Z;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • 2.2. Immunization and collection of specimens

    Mice were anesthetized with isoflurane before receiving the vaccine preparation for intranasal immunization. A 20-µl phosphate-buffered saline (PBS) solution containing the Mtb antigen ESAT-6 (5 µg; MyBioSource; MBS204541) in the presence or absence of S100A4 (10 µg; Gentaur Molecular Products; 01-2081A4M; with His-tag) was administered dropwise to the external nares of the mice (10 µl per nostril). Some mice were immunized with ESAT-6 (5 µg) admixed to cholera toxin (CT; 1 μg; List Biological Labs; 100B) as a control adjuvant. Ten days after the last intranasal immunization, various tissues and samples were collected and analyzed, including blood, bronchoalveolar lavage fluid (BALF), nasal lavage, lungs, and spleen.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

A stress sensor, IRE1a, is required for bacterialexotoxin-induced interleukin-1b production in tissue-resident macrophages

Sasaki, I;Fukuda-Ohta, Y;Nakai, C;Wakaki-Nishiyama, N;Okamoto, C;Okuzaki, D;Morita, S;Kaji, S;Furuta, Y;Hemmi, H;Kato, T;Yamamoto, A;Tosuji, E;Saitoh, SI;Tanaka, T;Hoshino, K;Fukuda, S;Miyake, K;Kuroda, E;Ishii, KJ;Iwawaki, T;Furukawa, K;Kaisho, T;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Kurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition

Gu, C;Liu, Y;Lv, J;Zhang, C;Huang, Z;Jiang, Q;Gao, Y;Tao, T;Su, Y;Chen, B;Jia, R;Liu, X;Su, W;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Induction of EAU model

    On the initial day of the experiment, the mice were administered a subcutaneous injection containing a 1:1 combination of 200 μg of human interphotoreceptor retinoid-binding protein 1–20 (IRBP1–20, GPTHLFQPSLVLDMAKVLLD; GiL Biochem, Shanghai, China) and complete Freund’s adjuvant (Difco, Detroit, MI, USA). The complete Freund’s adjuvant consisted of 2.5 mg/mL of Mycobacterium tuberculosis (BD Difco, San Jose, CA, USA). On the same day of immunization and two days thereafter, an intraperitoneal injection of 0.25 μg pertussis toxin (PTX) diluted in phosphate-buffered saline (PBS) was administered. The PTX used in this study was obtained from List Biological Laboratories located in Campbell, California, USA.

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation

Huang, N;Winans, T;Wyman, B;Oaks, Z;Faludi, T;Choudhary, G;Lai, ZW;Lewis, J;Beckford, M;Duarte, M;Krakko, D;Patel, A;Park, J;Caza, T;Sadeghzadeh, M;Morel, L;Haas, M;Middleton, F;Banki, K;Perl, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • Induction of MOG 35-55 peptide-induced EAE

    On Day 0, ~12-week-old female mice were immunized subcutaneously with 200 µg of MOG 35-55 peptide (MEVGWYRSPFSRVVHLYRNGK)118 and 400 µg of Mycobacterium tuberculosis H37Ra (MTb, Difco, Detroit, MI). Incomplete Freund’s Adjuvant (IFA; Gibco, Grand Island, NY) and dried, heat-killed MTb were emulsified with an equal volume of MOG 35-55 dissolved in PBS using a VirTishear Cyclone homogenizer with a 10 mm micro shaft impeller (VirTis, Gardiner, NY). The mice were immunized with 150 µl of the MOG-containing emulsion divided among three subcutaneous sites on the flank (between the shoulder blades and over each hip). Additionally, on Days 0 and 2, the mice were injected intraperitoneally with 200 ng pertussis toxin (PTx) (List Biological Laboratories, Campbell, CA) in 200 µl PBS119.

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)